These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 877853

  • 21. Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors.
    Kawamura K, Bahar R, Natsume W, Sakiyama S, Tagawa M.
    Cancer Gene Ther; 2002 Jan; 9(1):109-15. PubMed ID: 11916240
    [Abstract] [Full Text] [Related]

  • 22. Interleukin generation in experimental colon cancer of rats: effects of tumor growth and tumor therapy.
    Ravikumar T, Rodrick M, Steele G, Marrazo J, O'Dwyer P, Dodson T, King V.
    J Natl Cancer Inst; 1985 Apr; 74(4):893-8. PubMed ID: 3872959
    [Abstract] [Full Text] [Related]

  • 23. Immunological analysis of A strain mice bearing the A-10 mammary adenocarcinoma.
    Tax A, Manson LA.
    Cancer Res; 1979 May; 39(5):1739-47. PubMed ID: 85488
    [Abstract] [Full Text] [Related]

  • 24. Successful treatment with DL-alpha-difluoromethylornithine in established human small cell variant lung carcinoma implants in athymic mice.
    Luk GD, Abeloff MD, Griffin CA, Baylin SB.
    Cancer Res; 1983 Sep; 43(9):4239-43. PubMed ID: 6409400
    [Abstract] [Full Text] [Related]

  • 25. Generation of tumor cell-reactive human monoclonal antibodies using peripheral blood lymphocytes from actively immunized colorectal carcinoma patients.
    Haspel MV, McCabe RP, Pomato N, Janesch NJ, Knowlton JV, Peters LC, Hoover HC, Hanna MG.
    Cancer Res; 1985 Aug; 45(8):3951-61. PubMed ID: 4016762
    [Abstract] [Full Text] [Related]

  • 26. Exposure of Sprague-Dawley rats to a 50-Hertz, 100-microTesla magnetic field for 27 weeks facilitates mammary tumorigenesis in the 7,12-dimethylbenz[a]-anthracene model of breast cancer.
    Thun-Battersby S, Mevissen M, Löscher W.
    Cancer Res; 1999 Aug 01; 59(15):3627-33. PubMed ID: 10446973
    [Abstract] [Full Text] [Related]

  • 27. Successful heterotransplantation of human colon cancer cells to athymic animals is related to tumor cell differentiation and growth kinetics and to host natural killer cell activity.
    Drewinko B, Moskwa P, Lotzovà E, Trujillo JM.
    Invasion Metastasis; 1986 Aug 01; 6(2):69-82. PubMed ID: 3700013
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Tumor-specific suppressor cells induced by immunization with spleen cells from tumor-bearing animals.
    Huber SA, Bigi G, Lucas ZJ.
    Cancer Res; 1980 Oct 01; 40(10):3477-83. PubMed ID: 6449281
    [Abstract] [Full Text] [Related]

  • 32. Characterization of growth properties and demonstration of the tumor-specific transplantation antigens of Morris hepatomas.
    Wepsic HT, Nickel R, Alaimo J.
    Cancer Res; 1976 Jan 01; 36(1):246-50. PubMed ID: 174809
    [Abstract] [Full Text] [Related]

  • 33. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 2000 Jul 01; 491():1-412. PubMed ID: 12563349
    [Abstract] [Full Text] [Related]

  • 34. Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy.
    Unfer RC, Hellrung D, Link CJ.
    Cancer Res; 2003 Mar 01; 63(5):987-93. PubMed ID: 12615713
    [Abstract] [Full Text] [Related]

  • 35. Antitumor activity of 1 M tegafur-0.4 M 5-chloro-2,4-dihydroxypyridine-1 M potassium oxonate (S-1) against human colon carcinoma orthotopically implanted into nude rats.
    Shirasaka T, Nakano K, Takechi T, Satake H, Uchida J, Fujioka A, Saito H, Okabe H, Oyama K, Takeda S, Unemi N, Fukushima M.
    Cancer Res; 1996 Jun 01; 56(11):2602-6. PubMed ID: 8653704
    [Abstract] [Full Text] [Related]

  • 36. Fetal antigens associated with adenovirus 12 mouse tumors.
    Akagi T.
    Acta Med Okayama; 1976 Dec 01; 30(6):385-95. PubMed ID: 138333
    [Abstract] [Full Text] [Related]

  • 37. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 01; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 38. Increase in immunogenicity with concomitant loss of tumorigenicity of respiratory tract carcinomas during in vitro culture.
    Jamasbi RJ, Nettesheim P.
    Cancer Res; 1979 Jul 01; 39(7 Pt 1):2466-70. PubMed ID: 87265
    [Abstract] [Full Text] [Related]

  • 39. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH, Daynes RA, Hodes RJ.
    J Immunol; 1986 Feb 15; 136(4):1521-7. PubMed ID: 2418117
    [Abstract] [Full Text] [Related]

  • 40. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE.
    Cancer Res; 1985 Jan 15; 45(1):25-31. PubMed ID: 3965136
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.